We are live on ! Find out more
EMFAT

Emerald Mutual Fund Advisers Trust Portfolio holdings

AUM $2.85B
1-Year Est. Return 140.52%
This Fund
S&P 500
This Quarter Est. Return
+6.53%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.58B
AUM Growth
-$143M
Cap. Flow
-$168M
Cap. Flow %
-10.64%
Top 10 Hldgs %
18.89%
Holding
232
New
21
Increased
61
Reduced
99
Closed
18

Top Buys

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$16.3M
2
AHCO icon
AdaptHealth
AHCO
+$14.4M
3
CELH icon
Celsius Holdings
CELH
+$14.3M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$11.8M
5
NOG icon
Northern Oil and Gas
NOG
+$11.5M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$22.5M
2
AVNT icon
Avient
AVNT
+$20M
3
ALKS icon
Alkermes
ALKS
+$18.8M
4
GTLS
Chart Industries
GTLS
+$14.2M
5
ONTO icon
Onto Innovation
ONTO
+$13.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.23%
2 Financials 15.84%
3 Industrials 14.44%
4 Technology 12.81%
5 Consumer Discretionary 12.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AHCO icon
51
AdaptHealth
AHCO
$759M
$13.1M 0.83%
+699,538
New +$14.4M
ISEE
52
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$13.1M 0.83%
+732,091
New +$9.61M
EE icon
53
Excelerate Energy
EE
$1.11B
$13M 0.82%
556,211
+46,406
+9% +$1.1M
NOG icon
54
Northern Oil and Gas
NOG
$2.35B
$12.9M 0.81%
469,776
+408,252
+664% +$11.5M
PTLO icon
55
Portillo's
PTLO
$321M
$12.4M 0.79%
631,152
+225,119
+55% +$4.95M
WOOF icon
56
Petco
WOOF
$794M
$11.9M 0.75%
1,069,941
-80,909
-7% -$1.18M
HLI icon
57
Houlihan Lokey
HLI
$9.02B
$11.7M 0.74%
155,802
-10,120
-6% -$820K
TNDM icon
58
Tandem Diabetes Care
TNDM
$1.56B
$11.5M 0.73%
240,460
-90,725
-27% -$4.97M
COLL icon
59
Collegium Pharmaceutical
COLL
$956M
$11.1M 0.7%
695,393
-12,446
-2% -$219K
RETA
60
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$11.1M 0.7%
440,718
+189,450
+75% +$5.25M
AMRC icon
61
Ameresco
AMRC
$1.36B
$11M 0.69%
165,242
-11,140
-6% -$684K
ANIP icon
62
ANI Pharmaceuticals
ANIP
$1.78B
$10.9M 0.69%
338,398
-18,467
-5% -$632K
IMGO
63
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
$10.5M 0.67%
699,960
-26
-0% -$422
ARIS
64
DELISTED
Aris Water Solutions
ARIS
$10.3M 0.65%
808,588
+52,033
+7% +$889K
PRVA icon
65
Privia Health
PRVA
$2.87B
$10.2M 0.65%
+300,375
New +$11.1M
RARE icon
66
Ultragenyx Pharmaceutical
RARE
$2.55B
$9.86M 0.62%
238,204
+71,866
+43% +$3.69M
CCOI icon
67
Cogent Communications
CCOI
$508M
$9.6M 0.61%
183,989
-8,729
-5% -$503K
TTI icon
68
TETRA Technologies
TTI
$1.26B
$9.32M 0.59%
2,595,623
+1,054,095
+68% +$4.15M
SUPN icon
69
Supernus Pharmaceuticals
SUPN
$2.77B
$9.26M 0.59%
273,568
+212,873
+351% +$6.93M
VIAV icon
70
Viavi Solutions
VIAV
$9.66B
$9.15M 0.58%
700,909
-276,022
-28% -$3.93M
GOSS icon
71
Gossamer Bio
GOSS
$87M
$9.03M 0.57%
753,981
-907,499
-55% -$11.3M
FIVE icon
72
Five Below
FIVE
$13.5B
$9.02M 0.57%
65,545
-3,980
-6% -$523K
ARVN icon
73
Arvinas
ARVN
$572M
$8.98M 0.57%
201,929
-26,562
-12% -$1.29M
TFIN icon
74
Triumph Financial Inc
TFIN
$1.82B
$8.59M 0.54%
157,982
-110,040
-41% -$7.24M
CHUY
75
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$8.49M 0.54%
366,376
-40,170
-10% -$897K
1 2
3
4 5

Similar funds

SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
YC
Yarbrough Capital Franklin, Tennessee $2.85B AUM 36.22% 1-Year Est. Return
AHSSHC
Adventist Health System Sunbelt Healthcare Corp Altamonte Springs, Florida $2.86B AUM 12.86% 1-Year Est. Return
CAM
Crake Asset Management London, United Kingdom $2.86B AUM 16.35% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's Q3 2022 Portfolio in Review

As of Q3 2022, Emerald Mutual Fund Advisers Trust held 232 positions worth $1.58B, down 8.3% from $1.73B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Mutual Fund Advisers Trust withdrew a net $168M in Q3 2022, closing 18 positions and reducing 99 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $22.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.

Against the trend, Emerald Mutual Fund Advisers Trust opened a new position in Blueprint Medicines worth $16.7M.

  • Emerald Mutual Fund Advisers Trust's largest Q3 2022 buy was Blueprint Medicines: 253,645 shares worth $16.7M.
  • Emerald Mutual Fund Advisers Trust added most to Northern Oil and Gas in Q3 2022, an estimated $11.5M increase.
  • Emerald Mutual Fund Advisers Trust's biggest Q3 2022 reduction was Avient, cutting an estimated $20M.
  • Emerald Mutual Fund Advisers Trust fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $22.5M.
  • Emerald Mutual Fund Advisers Trust's ten largest holdings make up 19% of its $1.58B portfolio in Q3 2022.
  • Emerald Mutual Fund Advisers Trust opened 21 new positions and closed 18 in Q3 2022.
  • Emerald Mutual Fund Advisers Trust's portfolio value fell 8.3% quarter-over-quarter to $1.58B.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2022, filed 25 Oct 2022.